AstraZeneca trial in United States remains on hold

US Health and Human Services Secretary Alex Azar said on Wednesday that the US trial of AstraZeneca PLC's COVID-19 vaccine remains on hold while the US Food and Drug Administration investigates a patient illness that shut down the global trial.
Azar said that the FDA's investigation, which has continued even after the trial has resumed outside of the United States, shows that the agency takes safety of the vaccine seriously.
Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy